DE69528109D1 - Thieno -1,5- benzodiazepin zur Behandlung gastrointestinaler Beschwerden - Google Patents

Thieno -1,5- benzodiazepin zur Behandlung gastrointestinaler Beschwerden

Info

Publication number
DE69528109D1
DE69528109D1 DE69528109T DE69528109T DE69528109D1 DE 69528109 D1 DE69528109 D1 DE 69528109D1 DE 69528109 T DE69528109 T DE 69528109T DE 69528109 T DE69528109 T DE 69528109T DE 69528109 D1 DE69528109 D1 DE 69528109D1
Authority
DE
Germany
Prior art keywords
benzodiazepine
thieno
treatment
gastrointestinal complaints
complaints
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69528109T
Other languages
English (en)
Inventor
Beverley Greenwood
David Lloyd Garver Nelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69528109D1 publication Critical patent/DE69528109D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69528109T 1994-06-03 1995-06-02 Thieno -1,5- benzodiazepin zur Behandlung gastrointestinaler Beschwerden Expired - Lifetime DE69528109D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/253,658 US5457101A (en) 1994-06-03 1994-06-03 Thieno[1,5]benzoidiazepine use

Publications (1)

Publication Number Publication Date
DE69528109D1 true DE69528109D1 (de) 2002-10-17

Family

ID=22961179

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528109T Expired - Lifetime DE69528109D1 (de) 1994-06-03 1995-06-02 Thieno -1,5- benzodiazepin zur Behandlung gastrointestinaler Beschwerden

Country Status (14)

Country Link
US (1) US5457101A (de)
EP (1) EP0685233B1 (de)
JP (1) JPH07330608A (de)
KR (1) KR960000229A (de)
CN (1) CN1119101A (de)
AU (1) AU684924B2 (de)
CA (1) CA2150517A1 (de)
DE (1) DE69528109D1 (de)
HU (1) HUT71598A (de)
IL (1) IL113912A (de)
NO (1) NO306977B1 (de)
NZ (1) NZ272231A (de)
TW (1) TW372872B (de)
ZA (1) ZA954358B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
TR199801797T2 (xx) * 1996-03-11 1998-12-21 Eli Lilly And Company �ki kutuplu bozukluk tedavisi.
CZ290498A3 (cs) * 1996-03-11 1999-10-13 Eli Lilly And Company Farmaceutický prostředek proti autistickým stavům
IL126203A (en) * 1996-03-25 2002-12-01 Lilly Co Eli A synergistic painkiller that contains olenzapine and another painkiller
CN1219878A (zh) * 1996-03-25 1999-06-16 伊莱利利公司 治疗疼痛的方法
EA000769B1 (ru) * 1996-03-25 2000-04-24 Эли Лилли Энд Компани Способ лечения при боли, вызванной мигренью
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
AU6955998A (en) * 1997-04-15 1998-11-11 Eli Lilly And Company Method for providing neuro-protective effects
US20030022889A1 (en) * 1997-04-15 2003-01-30 Bymaster Franklin P. Method for providing neuro-protective effects
ATE253364T1 (de) * 1998-11-23 2003-11-15 Sepracor Inc Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungen
ES2237188T3 (es) * 1998-11-23 2005-07-16 Sepracor Inc. Composiciones de desmetilolanzapina y metodos.
WO2000030648A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
US6348458B1 (en) 1999-12-28 2002-02-19 U & I Pharmaceuticals Ltd. Polymorphic forms of olanzapine
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
UA80095C2 (en) * 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
GB0207091D0 (en) * 2002-03-26 2002-05-08 Ml Lab Plc Method of treatment
US7407788B2 (en) * 2002-11-21 2008-08-05 Danisco A/S, Genencor Division BGL7 beta-glucosidase and nucleic acids encoding the same
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
GB0314149D0 (en) * 2003-06-18 2003-07-23 Generics Uk Ltd Novel amorphous forms
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I
AR047459A1 (es) * 2004-01-27 2006-01-18 Synthon Bv Sales estables de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b][1,5]benzodiazepina (olanzapina)
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP1853234A2 (de) * 2005-02-15 2007-11-14 Elan Pharma International Limited Aerosol und injizierbare formulierungen aus benzodiazepin in form von nanoteilchen
EP1919923A1 (de) * 2005-08-17 2008-05-14 Synthon B.V. Verfahren zur herstellung von olanzapin form i
US20070293479A1 (en) * 2006-05-18 2007-12-20 Osinga Niels J Olanzapine pharmaceutical composition
AR063043A1 (es) * 2006-09-29 2008-12-23 Synthon Bv Composicion farmaceutica de olanzapina
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US9751847B2 (en) 2010-10-14 2017-09-05 University Of Utah Research Foundation Methods and compositions related to neuroactive thiazoline compounds
EP3497105A1 (de) * 2016-08-11 2019-06-19 Eli Lilly And Company Aminothiazine und deren verwendung als bace1-inhibitoren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
NO305125B1 (no) * 1992-05-29 1999-04-06 Lilly Industries Ltd Farmas°ytiske forbindelser
EP0620222A3 (de) * 1993-04-14 1995-04-12 Lilly Co Eli Tetrahydro-betacarboline.
AU679635B2 (en) * 1994-03-11 1997-07-03 Eli Lilly And Company Method for treating 5HT-2B receptor related conditions

Also Published As

Publication number Publication date
KR960000229A (ko) 1996-01-25
EP0685233A3 (de) 1996-04-03
EP0685233B1 (de) 2002-09-11
NO952130D0 (no) 1995-05-30
NZ272231A (en) 2001-05-25
HUT71598A (en) 1996-01-29
NO306977B1 (no) 2000-01-24
AU684924B2 (en) 1998-01-08
AU2042495A (en) 1995-12-14
NO952130L (no) 1995-12-04
JPH07330608A (ja) 1995-12-19
US5457101A (en) 1995-10-10
EP0685233A2 (de) 1995-12-06
TW372872B (en) 1999-11-01
CA2150517A1 (en) 1995-12-04
CN1119101A (zh) 1996-03-27
HU9501600D0 (en) 1995-07-28
IL113912A (en) 1999-04-11
ZA954358B (en) 1996-11-29
IL113912A0 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
DE69528109D1 (de) Thieno -1,5- benzodiazepin zur Behandlung gastrointestinaler Beschwerden
ATE224189T1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
ATE305788T1 (de) (s,s)-reboxetin zur behandlung von inkontinenz
DE59712045D1 (de) Vorrichtung zur behandlung des herzens
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE60045386D1 (de) Gerät zur thermischen behandlung von bandscheiben
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69927823T2 (de) Hydrogel für die therapeutische behandlung von aneurysmas
DE69806579D1 (de) Anlage zur behandlung von nahrungsmitteln
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60136477D1 (de) Retinoide zur behandlung von emphysem
NO20003042L (no) FremgangsmÕte for profylaktisk behandling av mastitt
DE69735162D1 (de) L-carnosin enthaltende mittel zur behandlung des nierenversagens
ATE347372T1 (de) Vakzine zur behandlung von mycosen
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
IS4789A (is) Meðferðarefnasambönd
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis

Legal Events

Date Code Title Description
8332 No legal effect for de